Balas E A, Boren S A, Hicks L L, Chonko A M, Stephenson K
Department of Health Management and Informatics, School of Medicine, University of Missouri, Columbia 65211, USA.
Med Care. 1998 Jan;36(1):79-87. doi: 10.1097/00005650-199801000-00009.
The purpose of this study was to evaluate the effect of clinical direct reports (practice data with pertinent evidence from the literature) on dialysis modality selection for patients with end-stage renal disease.
A randomized controlled clinical trial was conducted at five dialysis centers. Five of the 10 physician participants were assigned through centralized computerized randomization to the intervention group (who received 12 center-specific clinical direct reports encouraging the consideration of peritoneal dialysis), and five were assigned to the control group, who received usual information but no similar report. One hundred fifty-two patients were eligible for monitoring.
The number of patients allocated to peritoneal dialysis was significantly higher in the intervention group than in the control group (15.3% versus 2.4%; P = 0.044). Due to a need for transient initial hemodialysis by some patients, the percentage of patients receiving peritoneal dialysis further increased through the end of the 3-month follow-up (18.0% versus 4.9%, P = 0.041).
There were no significant differences between the intervention and control groups in meeting patient preferences, metabolic status, and complication rates. The results of this study show that linking pertinent published evidence to actual practice data can support the implementation of practice recommendations and influence the selection of dialysis treatment for new patients.
本研究旨在评估临床直接报告(结合文献相关证据的实践数据)对终末期肾病患者透析方式选择的影响。
在五个透析中心进行了一项随机对照临床试验。10名医生参与者中的5名通过集中计算机随机分组被分配到干预组(接受12份特定中心的临床直接报告,鼓励考虑腹膜透析),另外5名被分配到对照组,接受常规信息但无类似报告。152名患者符合监测条件。
干预组分配到腹膜透析的患者数量显著高于对照组(15.3%对2.4%;P = 0.044)。由于一些患者需要进行短暂的初始血液透析,到3个月随访结束时,接受腹膜透析的患者百分比进一步增加(18.0%对4.9%,P = 0.041)。
干预组和对照组在满足患者偏好、代谢状况和并发症发生率方面无显著差异。本研究结果表明,将相关已发表证据与实际实践数据相结合可支持实践建议的实施,并影响新患者透析治疗的选择。